Vanguard Group Inc Acadia Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 15,264,240 shares of ACAD stock, worth $320 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,264,240

Previous 15,203,234 0.4%

Holding current value

$320 Million

Previous $253 Million 30.38%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$14.1 - $22.95 $860,184 - $1.4 Million	61,006 Added 0.4%	15,264,240 $329 Million
Q1 2025 May 09, 2025	BUY	$16.61 - $20.29 $20.9 Million - $25.5 Million	1,255,594 Added 9.0%	15,203,234 $253 Million
Q4 2024 Feb 11, 2025	BUY	$14.29 - $18.76 $1.49 Million - $1.96 Million	104,444 Added 0.75%	13,947,640 $256 Million
Q3 2024 Nov 13, 2024	BUY	$15.14 - $19.14 $1.98 Million - $2.51 Million	131,065 Added 0.96%	13,843,196 $213 Million
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $6.05 Million - $7.62 Million	413,590 Added 3.11%	13,712,131 $223 Million
Q1 2024 May 10, 2024	SELL	$17.79 - $30.86 $1.73 Million - $3.01 Million	-97,468 Reduced 0.73%	13,298,541 $246 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $4.59 Million - $7.01 Million	-220,731 Reduced 1.62%	13,396,009 $419 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $4.96 Million - $7.97 Million	-238,106 Reduced 1.72%	13,616,740 $284 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $3.13 Million - $4.52 Million	176,037 Added 1.29%	13,854,846 $332 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $6.51 Million - $8.35 Million	399,034 Added 3.0%	13,678,809 $257 Million
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $5.03 Million - $6.6 Million	354,134 Added 2.74%	13,279,775 $211 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $7.41 Million - $9.59 Million	525,048 Added 4.23%	12,925,641 $211 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $2.34 Million - $4.91 Million	-180,221 Reduced 1.43%	12,400,593 $175 Million
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $5.56 Million - $7.3 Million	265,448 Added 2.16%	12,580,814 $305 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $3.12 Million - $5.04 Million	186,100 Added 1.53%	12,315,366 $287 Million
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $9.64 Million - $15.1 Million	610,949 Added 5.3%	12,129,266 $201 Million
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $223 Million - $316 Million	11,518,317 New	11,518,317 $281 Million

Others Institutions Holding ACAD

# of Institutions

350

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Acadia Pharmaceuticals Inc Transaction History